TY - JOUR
T1 - Involvement of transforming growth factor-β1 signaling in hypoxia-induced tolerance to glucose starvation
AU - Suzuki, Atsushi
AU - Kusakai, Gen Ichi
AU - Shimojo, Yosuke
AU - Chen, Jian
AU - Ogura, Tsutomu
AU - Kobayashi, Masanobu
AU - Esumi, Hiroyasu
PY - 2005/9/9
Y1 - 2005/9/9
N2 - Because survival and growth of human hepatoma cells are maintained by nutrient, especially glucose, glucose starvation induces acute cell death. The cell death is markedly suppressed by hypoxia, and we have reported involvement of AMP-activated protein kinase-α (AMPK-α), Akt, and ARK5 in hypoxia-induced tolerance. In the current study we investigated the mechanism of hypoxia-induced tolerance in human hepatoma cell line HepG2. ARK5 expression was induced in HepG2 cells when they were subjected to glucose starvation, and we found that glucose starvation transiently induced Akt and AMPK-α phosphorylation and that hypoxia prolonged phosphorylation of both protein kinases. We also found that hypoxia-induced tolerance was partially abrogated by blocking the Akt/ARK5 system or by suppressing AMPK-α expression and that suppression of both completely abolished the tolerance, suggesting that AMPK-α activation signaling and the Akt/ARK5 system play independent essential roles in hypoxia-induced tolerance. By using chemical compounds that specifically inhibit kinase activity of type I-transforming growth factor-β (TGF-β) receptor, we showed an involvement of TGF-β in hypoxia-induced tolerance. TGF-β1 mRNA expression was induced by hypoxia in an hypoxia-inducible factor-1α-independent manner, and addition of recombinant TGF-β suppressed cell death during glucose starvation even under normoxic condition. AMPK-α, Akt, and ARK5 were activated by TGF-β1, and Akt and AMPK-α phosphorylation, which was prolonged by hypoxia, was suppressed by an inhibitor of type I TGF-β receptor. Based on these findings, we propose that hypoxia-induced tumor cell tolerance to glucose starvation is caused by hypoxia-induced TGF-β1 through AMPK-α activation and the Akt/ARK5 system.
AB - Because survival and growth of human hepatoma cells are maintained by nutrient, especially glucose, glucose starvation induces acute cell death. The cell death is markedly suppressed by hypoxia, and we have reported involvement of AMP-activated protein kinase-α (AMPK-α), Akt, and ARK5 in hypoxia-induced tolerance. In the current study we investigated the mechanism of hypoxia-induced tolerance in human hepatoma cell line HepG2. ARK5 expression was induced in HepG2 cells when they were subjected to glucose starvation, and we found that glucose starvation transiently induced Akt and AMPK-α phosphorylation and that hypoxia prolonged phosphorylation of both protein kinases. We also found that hypoxia-induced tolerance was partially abrogated by blocking the Akt/ARK5 system or by suppressing AMPK-α expression and that suppression of both completely abolished the tolerance, suggesting that AMPK-α activation signaling and the Akt/ARK5 system play independent essential roles in hypoxia-induced tolerance. By using chemical compounds that specifically inhibit kinase activity of type I-transforming growth factor-β (TGF-β) receptor, we showed an involvement of TGF-β in hypoxia-induced tolerance. TGF-β1 mRNA expression was induced by hypoxia in an hypoxia-inducible factor-1α-independent manner, and addition of recombinant TGF-β suppressed cell death during glucose starvation even under normoxic condition. AMPK-α, Akt, and ARK5 were activated by TGF-β1, and Akt and AMPK-α phosphorylation, which was prolonged by hypoxia, was suppressed by an inhibitor of type I TGF-β receptor. Based on these findings, we propose that hypoxia-induced tumor cell tolerance to glucose starvation is caused by hypoxia-induced TGF-β1 through AMPK-α activation and the Akt/ARK5 system.
UR - http://www.scopus.com/inward/record.url?scp=24744451416&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=24744451416&partnerID=8YFLogxK
U2 - 10.1074/jbc.M503714200
DO - 10.1074/jbc.M503714200
M3 - Article
C2 - 16014625
AN - SCOPUS:24744451416
SN - 0021-9258
VL - 280
SP - 31557
EP - 31563
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 36
ER -